Bio-Rad Laboratories’ Post

Join Guidehouse's Life Sciences Commercial Transformation leaders at the Fierce Biotech Summit in Boston on September 30. Connect with industry leaders and executives to learn about advancements, innovations, and the future of biotech. #productlaunch #biotech #innovation

In 2024, the #biotech sector finds itself at a pivotal point, characterized by accelerated advancements and evolving market dynamics. This edition of Seamless Clinical Insights explores the current biotech atmosphere, highlighting opportunities for this year and beyond. #Subscribe to our newsletter today to gain actionable insights for your journey to clinical success: https://bit.ly/3WDYh5F

Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry. Discover how to navigate the complexities of funding and innovation in the biotech sector in our latest article: https://okt.to/ugJm1o #Biotech #LifeSciences

🚀 Leading the Charge in Biotechnology 🚀 At Biovivium Strategies, we’re not just keeping up with the biotech revolution—we’re shaping it. Our strategic consulting services are designed to guide organizations through the complexities of modern research, from optimizing clinical trial design to integrating cutting-edge technologies. Let us help you turn innovative ideas into impactful realities. #Biotechnology #Innovation #BioviviumStrategies #ClinicalResearch

Exciting insights from our recent roundtables, hosted in partnership with @AusBiotech. We were joined by more than 90 Biotech CEOs to discuss funding challenges, navigating regulatory changes, and talent acquisition. Read more about our discussions and how we can support your journey: https://lnkd.in/gwNc4P48

✨ We are pleased to announce that Piotr Garstecki will represent Scope Fluidics at the PHASE - Polish Healthcare Assets Sector Event Conference, which is the largest discussion on Polish biotechnology. 🔹 The PHASE - Polish Healthcare Assets Sector Event Conference is aimed at all those interested in medical biotechnology, including: ▪ Capital market participants  ▪ Representatives of public institutions  ▪ Entrepreneurs  ▪ Scientists 🔹 The PHASE - Polish Healthcare Assets Sector Event will be held on August 27-29, 2024. ◾ Two days and more than a dozen panels in five main thematic blocks: Economy, Investment, Business, Technology, Science. The third day will be dedicated to investor presentations of companies. ◾ Presentation of the report of the Polish Union of Innovative Medical Biotechnology Companies BioInMed "Impact of the medical biotechnology sector on the Polish economy and medical progress". 🌍 www - https://lnkd.in/dpj26xHs #PHASE2024 #biotechnology #scopefluidics #biotech

🔬✨ In this week's #TechTales post, we talk about the versatility of our MOFs in encapsulating and transporting various types of cargo for targeted drug delivery. At Vector Bioscience Cambridge, we customise our #NanoShuttles to optimise the encapsulation of any treatment, molecule, or combination of them. Our platform technology is cargo-agnostic, allowing for more precise and localised drug delivery and controlled drug release. This adaptability is crucial as it allows for the development of tailored therapies enhancing treatment effectiveness and patient outcomes. Stay tuned for our next #TechTales posts as we continue to explore the science driving our breakthroughs. 🚀🔗 #DrugDelivery #Nanotechnology #Biopharma #Biotech #Innovation #MOFs #CancerTreatment

People make more patient decisions when shown the benefits first https://lnkd.in/ggyhf_3h The post People make more patient decisions when shown the benefits first appeared first on Life Sciences. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

More employees, lower total revenue, and a promising research pipeline: In the current EY Biotech report 2024 you can read about the state of the industry: https://lnkd.in/epFWTzMF #EYbiotech #BetterQuestions #BetterAnswers

There is Scope in Biotech! 💪Case Studies of Successful Biotechnologists - A Biotecnika Initiative 😇 👇 https://lnkd.in/garwDfEM #scope #biotechnology #casestudy #biotech #career #success